Tuesday, 18 October 2016 - London, Park Plaza Victoria London
Official language: English
The new pharmacovigilance legislation was enforced in the European Union as early as July 2012 and there has been no dearth of Hot Topics in Pharmacovigilance for discussion. Specifically, 2016 is expected to be an intriguing year for professionals dealing with the safety of drugs, biologics and medical devices. With increasing regulatory expectations and innovative initiatives in place, the pharmacovigilance space in the EU is being watched by the whole world. At such a time, it becomes imperative to collate the thoughts of all stakeholders of pharmacovigilance on the same platform. UK Pharmacovigilance Day 2016 conference looks forward to accomplishing this daunting task with a great deal of passion and commitment.
During the conference, expert speakers from the industry, regulatory agencies, research bodies, academia and healthcare delivery centres will take you through the new trends in the discipline and deliberate on the challenges they face in 2016, with the topics of focus ranging from Medical Literature Monitoring (MLM) service of EMA, Social Media screening in Pharmacovigilance, Inspections/Audit Findings, Risk Minimization to name a few.
Dr J Vijay Venkatraman, Managing Director & CEO at Oviya MedSafe
Dr Seema Jaitly, Managing Director at Essjay Solutions Ltd
The seminar is ideally suited for employees of small-, middle- and large-sized companies in the pharmaceutical sector especially concerned with the implementation and/or maintenance of Pharmacovigilance/Vigilance Systems, with its critical processes and quality system. Participants may come from various departments involved in fulfilling Pharmacovigilance/Vigilance requirements as legal Medical Affairs and Regulatory Affairs.